BAILEY WOODWARD: Open Payments
NPI 1548915531 · RAYVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 41 payments from 14 companies in 2025. Trend: 2023 $510 · 2024 $458 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $137 |
| ABBVIE INC. | 5 | $93 |
| Novo Nordisk Inc | 3 | $62 |
| Exact Sciences Corporation | 4 | $61 |
| Insulet Corporation | 2 | $53 |
| PFIZER INC. | 2 | $39 |
| Amgen Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Corcept Therapeutics | 1 | $30 |
Products named: AIRSUPRA, CAPLYTA, Cologuard Collection Kit, UBRELVY, Omnipod, BREZTRI, Ozempic, Auvelity.
Industry payments across LA — which companies pay providers there.
